World Stroke Organization 
CVST represents ~ 1% of strokes. It most commonly affect young individuals with transient (pregnancy, use of oral contraceptives) or permanent (thrombophilia) predisposing conditions. Several studies showed a delay in the diagnosis and treatment, a common cause of neurological deterioration that results in poor clinical outcomes. This webinar will offer a comprehensive approach to increase awareness among neurologists & SSO members on the recognition of initial symptoms, the diagnosis and management of patients with CVST.
Topics:
- Diagnosis, Endovascular and Surgical Management of Cerebral Venous Thrombosis (Jonathan Coutinho)
- Cerebral venous thrombosis: Epidemiology and antithrombotic treatment (Thalia S. Field)
- Cerebral Venous Sinus Thrombosis and Vaccine-Induced Thrombotic Thrombocytopenia (Karen Furie)
Learning Objectives:
- To learn about the clinical presentation and associated factors to CVST
- To review evidence-based therapeutic options
- To discuss about CVST in the Covid-19 Era: VITT diagnosis and treatment
Date and time:
4 PM CEST on 29 September, 2021
Webinar Details
Speakers:
- Jonathan Coutinho - Stroke Neurologist, Amsterdam University Medical Centers, The Netherlands
- Thalia Shoshana - Stroke Neurologist, University of British Columbia
- Karen Furie - Chief of Neurology, Rhode Island, The Miriam and Bradley Hospitals
Moderator:
- Gustavo Saposnik - Associate Professor of Medicine (Neurology) at the University of Toronto, Canada - Editor in Chief, WSA
;
